Skip to main content
logo
Ventyx Biosciences, Inc. (VTYX)
Mar 4, 2026 - VTYX was delisted (reason: acquired by LLY)
14.00
+0.02 (0.14%)
Inactive · Last trade price on Mar 3, 2026

Ventyx Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1,0051551461,857999-
Market Cap Growth
730.87%6.21%-92.15%85.92%--
Enterprise Value
822-109-1431,4461,081-
Last Close Price
14.002.192.4732.7919.86-

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PB Ratio
5.220.610.605.253.58-
P/TBV Ratio
5.250.610.605.253.58-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.050.040.050.00--0.41
Net Debt / Equity Ratio
-0.95-0.95-0.98-1.00-1.03-0.40
Net Debt / EBITDA Ratio
1.571.631.153.144.27-
Net Debt / FCF Ratio
2.081.851.443.597.37-2.00
Quick Ratio
17.1517.0911.3619.4321.050.17
Current Ratio
17.8617.9711.8720.2121.410.18
Return on Equity (ROE)
-45.35%-54.27%-64.55%-34.25%-67.39%-
Return on Assets (ROA)
-28.46%-33.48%-40.05%-21.33%-28.77%-1483.59%
Return on Capital Employed (ROCE)
-58.30%-56.30%-81.40%-31.90%-24.00%608.80%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-10.61%-87.26%-132.35%-5.84%-8.38%-
FCF Yield
-8.75%-84.67%-114.57%-5.33%-3.90%-
Buyback Yield / Dilution
-8.51%-16.97%-11.57%-309.11%-544.96%-19.64%
SEC Filings: 10-K · 10-Q